Relapsing Multiple Sclerosis (RMS) Completed Phase 3 Trials for Ibuprofen (DB01050)

Also known as: Multiple Sclerosis Relapse / Relapsed Multiple sclerosis / Relapsing Multiple Sclerosis / Multiple sclerosis flare

IndicationStatusPhase
DBCOND0044896 (Relapsing Multiple Sclerosis (RMS))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00619307Transition to Rebif New FormulationSupportive Care